Alternatives to Imagene

AI-powered technology platform improving accuracy and efficiency in pathology diagnosis and drug development research.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI-powered spatial biology platform for precision medicine and drug development.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Harnessing genetic data for digital insights in rare and germline disorders.

Designs and creates novel enzymes for sustainable and cost-effective bioproduction.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Developing novel diagnostics to predict patient response to immunotherapy.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

Transforming healthcare by turning scientific fiction into scientific facts.

Develops a computational model of the human body for drug discovery and development.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.